BlackRock, Inc. 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 3:04 pm Purchase | 2021-01-31 | 13G | Crescent Biopharma, Inc. CBIO | BlackRock Inc. BLK | 3,429 4.400% | 13 (+0.38%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | BlackRock Inc. BLK | 3,416 6.100% | 2,716 (+388.05%) | Filing |